Nevertheless, the role of FXR in cholestasis is controversial [8,12–15] since, FXR gene ablation or administration of an FXR antagonist[16] protects against liver damage caused by bile duct ligation (BDL), a severe model of obstructive choelstasis[14–15]. The gene discussed is NR1H4; the disease is cholestasis.